Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Non-Current Deffered Revenue (2020 - 2025)

Caribou Biosciences has reported Non-Current Deffered Revenue over the past 6 years, most recently at $1.8 million for Q4 2025.

  • Quarterly Non-Current Deffered Revenue fell 47.18% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, down 47.18% year-over-year, with the annual reading at $1.8 million for FY2025, 47.18% down from the prior year.
  • Non-Current Deffered Revenue was $1.8 million for Q4 2025 at Caribou Biosciences, roughly flat from $1.8 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $24.2 million in Q2 2021 and troughed at $1.8 million in Q4 2025.
  • The 5-year median for Non-Current Deffered Revenue is $5.8 million (2023), against an average of $9.3 million.
  • Year-over-year, Non-Current Deffered Revenue skyrocketed 660.8% in 2022 and then tumbled 74.65% in 2024.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $2.1 million in 2021, then skyrocketed by 660.8% to $16.0 million in 2022, then crashed by 61.75% to $6.1 million in 2023, then crashed by 45.64% to $3.3 million in 2024, then tumbled by 47.18% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Non-Current Deffered Revenue are $1.8 million (Q4 2025), $1.8 million (Q3 2025), and $1.8 million (Q2 2025).